![Yan Bin Wang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yan Bin Wang
Directeur/Membre du Conseil chez Nanjing Bioheng Biotech Co., Ltd.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Xiao Hong He | M | - |
Nanjing Bioheng Biotech Co., Ltd.
![]() Nanjing Bioheng Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Nanjing Bioheng Biotech Co., Ltd. specializes in novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. The company was founded by Xiao Hong He on March 27, 2017 and is headquartered in Nanjing, China. | 7 ans |
Hai Bo Qian | M | 61 |
Nanjing Bioheng Biotech Co., Ltd.
![]() Nanjing Bioheng Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Nanjing Bioheng Biotech Co., Ltd. specializes in novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. The company was founded by Xiao Hong He on March 27, 2017 and is headquartered in Nanjing, China. | 6 ans |
Xiang Ming Cui | M | 55 |
Nanjing Bioheng Biotech Co., Ltd.
![]() Nanjing Bioheng Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Nanjing Bioheng Biotech Co., Ltd. specializes in novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. The company was founded by Xiao Hong He on March 27, 2017 and is headquartered in Nanjing, China. | - |
Jiang Tao Ren | M | - |
Nanjing Bioheng Biotech Co., Ltd.
![]() Nanjing Bioheng Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Nanjing Bioheng Biotech Co., Ltd. specializes in novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. The company was founded by Xiao Hong He on March 27, 2017 and is headquartered in Nanjing, China. | - |
Su Wang | M | - |
Nanjing Bioheng Biotech Co., Ltd.
![]() Nanjing Bioheng Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Nanjing Bioheng Biotech Co., Ltd. specializes in novel immunotherapy and next-generation gene therapy development for treating cancers and various diseases. The company was founded by Xiao Hong He on March 27, 2017 and is headquartered in Nanjing, China. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Chine | 5 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Yan Bin Wang
- Réseau Personnel